Virtual Clinical Trials

Your trial technology, our in-home staffing

Electronic platforms are making virtual trials possible and are facilitating the adoption of this newer trial model.

Even with comprehensive technology, these trials nearly all require some in-home clinical trial support or localized medical oversight.

PanAmerican partners with sponsors and research organizations adopting this technology.

Virtual Clinical Trial Services

  • Informed consent discussions & documentation  
  • Study drug delivery & administration
  • IV infusions
  • Biological sample collection, processing, & packaging
  • Health screenings & vital sign assessments
  • Patient & caregiver training 
  • Monitoring
  • Translations 

Case Study

Client: Small Biopharma Company

Ask: Support the in-home portion of an otherwise virtual trial in Mexico.

Situation: The rare disease trial was not suited to a traditional model and required community outreach and recruitment and various in-home visits.  

PanAmerican Solution: PanAmerican leveraged its staff epidemiologists and local knowledge to identify three communities with disease prevalence and built rapport within these communities and health clinics serving these areas in order to identify participants. PanAmerican home health providers trained each participant and family members on study procedures, attended those visits requiring blood draws and IV infusion, and supported the use of the virtual trial platform. 

PanAmerican Result: A successfully completed trial that hit enrollment targets and produced quality data. What was a trial once thought not feasible, was made a reality by the virtual clinical trial model, technology, and PanAmerican’s ability to recruit outside of traditional research sites.

“For our virtual trial, PanAmerican assessed the appropriate regions to perform the trial, recruited the participants, and performed the in-home visits. The level of recruitment, retention, and quality data collection were impressive. By eliminating the majority of sites and moving to a virtual model, we were able to execute what we thought was an implausible trial.”